|
2018-09-04 |
2018-08-30 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
82 304
-55.6%
27,40
2 255 492 USD
|
82 304
-55.6%
|
27,40
|
2 255 492 USD
|
|
|
2018-08-17 |
2018-08-16 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
1 480
-2.2%
20,08
29 715 USD
|
1 480
-2.2%
|
20,08
|
29 715 USD
|
|
|
2018-08-17 |
2018-08-16 |
VP
Vente planifiée
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
695
-3.0%
20,19
14 035 USD
|
695
-3.0%
|
20,19
|
14 035 USD
|
|
|
2018-07-06 |
2018-07-03 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
867
-1.3%
22,47
19 482 USD
|
867
-1.3%
|
22,47
|
19 482 USD
|
|
|
2018-06-08 |
2018-06-08 |
VP
Vente planifiée
|
MORATIS GEORGE Z
Global Accounting Officer
|
455
-2.2%
22,81
10 378 USD
|
455
-2.2%
|
22,81
|
10 378 USD
|
|
|
2017-08-24 |
2017-08-23 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
1 332
-0.7%
23,30
31 036 USD
|
1 332
-0.7%
|
23,30
|
31 036 USD
|
|
|
2017-08-16 |
2017-08-15 |
VP
Vente planifiée
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
1 090
-0.5%
24,08
26 247 USD
|
1 090
-0.5%
|
24,08
|
26 247 USD
|
|
|
2017-08-16 |
2017-08-15 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
|
2 350
-4.1%
24,08
56 588 USD
|
2 350
-4.1%
|
24,08
|
56 588 USD
|
|
|
2017-08-16 |
2017-08-15 |
VP
Vente planifiée
|
MORATIS GEORGE Z
Global Accounting Officer
|
770
-4.5%
24,09
18 549 USD
|
770
-4.5%
|
24,09
|
18 549 USD
|
|
|
2017-08-15 |
2017-08-11 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
|
39 357
-40.6%
23,37
919 631 USD
|
39 357
-40.6%
|
23,37
|
919 631 USD
|
|
|
2017-07-05 |
2017-07-01 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
Dirigeant
|
956
-1.6%
24,33
23 259 USD
|
956
-1.6%
|
24,33
|
23 259 USD
|
|
|
2017-06-16 |
2017-06-16 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
|
13 787
-19.1%
22,73
313 379 USD
|
13 787
-19.1%
|
22,73
|
313 379 USD
|
|
|
2017-06-16 |
2017-06-15 |
VP
Vente planifiée
|
Cole Gregory S
Chief Financial Officer
|
29 160
-33.4%
22,83
665 723 USD
|
29 160
-33.4%
|
22,83
|
665 723 USD
|
|
|
2017-05-30 |
2017-05-25 |
V
Vente
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Administrateur exécutif
|
50 000
-20.1%
22,70
1 135 000 USD
|
50 000
-20.1%
|
22,70
|
1 135 000 USD
|
|
|
2017-05-15 |
2017-05-12 |
V
Vente
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
800
-6.0%
21,77
17 419 USD
|
800
-6.0%
|
21,77
|
17 419 USD
|
|
|
2017-05-15 |
2017-05-12 |
V
Vente
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
200
-1.5%
21,77
4 354 USD
|
200
-1.5%
|
21,77
|
4 354 USD
|
|
|
2017-05-10 |
2017-05-10 |
V
Vente
|
MORATIS GEORGE Z
Global Accounting Officer
Dirigeant
|
902
-6.3%
21,61
19 492 USD
|
902
-6.3%
|
21,61
|
19 492 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Vente
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Actionnaire important
|
3 926 068
-42.2%
20,23
79 424 356 USD
|
3 926 068
-42.2%
|
20,23
|
79 424 356 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Vente
|
WCAS Capital Partners IV, L.P.
Actionnaire important
|
57 488
-42.2%
20,23
1 162 982 USD
|
57 488
-42.2%
|
20,23
|
1 162 982 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Vente
|
WCAS MANAGEMENT CORP
Actionnaire important
|
3 214
-42.2%
20,23
65 019 USD
|
3 214
-42.2%
|
20,23
|
65 019 USD
|
|
